Determination of molecular properties effectuating the growth inhibition of mycobacterium tuberculosis by various small molecule hydrazides

Letters in Drug Design and Discovery

Volumn 5, Issue 3, 2008, Pages 162-168

  Bartzatt, Ronald ^a   Cirillo, Suat L G ^b   Cirillo, Jeffrey D ^b  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b TEXAS A AND M UNIVERSITY SYSTEM   (United States)

Author keywords

Bacteria; Isoniazid; Mycobacterium tuberculosis; TB

Indexed keywords

2 (4 ISOBUTYLPHENYL) PROPANEHYDRAZIDE; 2 HYDRAZINOCARBONYL PHENYL ACETATE; 2 METHYLENESUCCINOHYDRAZIDE; ACETYLSALICYLIC ACID; DICARBOXYLIC ACID; DODECANOHYDRAZIDE; HYDRAZIDE DERIVATIVE; IBUPROFEN; ISONIAZID; ITACONIC ACID; LAURIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; ATOM; BACTERIAL GROWTH; BLOOD BRAIN BARRIER; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; GROWTH INHIBITION; IN VITRO STUDY; LIPOPHILICITY; MOLECULE; MULTIPLE REGRESSION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 42149104449     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018008784083929     Document Type: Article

References (25)

1. Iademarco, M.F.; Castro, K.G. Semin. Respir. Infect., 2003, 18, 225.
2. Raviglione, M.C.; O'Brien, R.J. Tuberculosis: Harrison's Principles of Internal Medicine, McGraw-Hill Professional: New York, 2004.
3. Sobero, R.; Peabody, J. Int. J. Tuberc. Lung Dis., 2006, 10(11), 1292.
4. Cox, R. Microbiology, 2004, 150(Pt 5), 1413.
5. Houben, J.; Nguyen, L.; Pieters, J. Curr. Opin, Microbiol., 2006, 9(1), 76.
6. Parish, T.; Stoker, N. Mol. Biotechnol., 1999, 13(3), 191.
7. O'Brien, R. Semin. Respir. Infect., 1994, 9(2), 104.
8. Timmins, G.S.; Deretic, V. Mol. Microbiol., 2006, 62(5), 1220.
9. Benfang, L.; Chih-Jen, W.; Shiao-Chun, T. J. Biol. Chem., 2000, 275(4), 2520.
10. Goble, M.; Iseman, M.D.; Madsen, L.A.; Waite, D.; Ackerson, L.; Harsburgh, C.R. N. Engl. J. Med., 1993, 328(8), 527.
11. Kehinde, A.O.; Obaseki, F.A.; Ishola, O.C.; Ibrahim, K.D. J. Natl. Med. Assoc., 2007, 99(10), 1185.
12. Tahaoglu, K.; Torun, T.; Sevim, T.; Atac, G.; Kir, A.; Karasulu, L.; Ozmen, I.; Kapaki, N. N. Engl. J. Med., 2001, 345(3), 208.
13. Gonlugur, T.E.; Gonlugur, U.; Hasbek, M. Acta Microbiol. Immunol. Hung., 2007, 54(4), 421.
14. Macedo, R.; Perdigli, J.; Brum, J.; Portugal, I. Riv. Port. Pneumol., 2007, 13(Suppl. 6), 20.
15. Greinert, U.; Hillemann, D.; Lange, C.; Richter, E. Med. Klin. (Munich), 2007, 102(12), 957.
16. Tomioka, H.; Namba, K. Kekkaku, 2006, 81(12), 753.
17. Pv, K.; Palarian, S.; Ojha, P.; Pr. S. Pak. J. Pharm. Sci., 2008, 21(1), 51.
18. Carvalho, S.A.; da Silva, E.F.; de Souza, M.V.; Laurenco, M.C.; Vicente, F.R. Bioorg. Med. Chem. Lett., 2007, 28, 1.
19. Lipinski, C.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Drug Deliv. Rev., 1997, 23, 3.
20. Bardou, F.; Raynaud, C.; Ramos, C.; Laneelle, M.A.; Laneelle, G. Microbiology, 1998, 144, 2539.
21. Palm, K.; Stenberg, P.; Luthman, K. Pharm. Res., 1997, 14, 568.
22. Clark, D.E. J. Pharm. Sci., 1999, 88, 815.
23. Clarke, K.R. Aust. J. Ecol., 1993, 18, 117.
24. Bow, S.T. Pattern Recognition, Marcel Dekker: New York, 1984.
25. Sha'Afi, R.I.; Gary-BoBo, C.M.; Solomon, A.K. J. Gen. Physiol., 1971, 58, 238.